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MaBACKGROUND Indoor exposure to ﬁne particulate matter (PM2.5) from outdoor sources is a major health concern,
especially in highly polluted developing countries such as China. Few studies have evaluated the effectiveness of indoor
air puriﬁcation on the improvement of cardiopulmonary health in these areas.
OBJECTIVES This study sought to evaluate whether a short-term indoor air puriﬁer intervention improves cardiopul-
monary health.
METHODS We conducted a randomized, double-blind crossover trial among 35 healthy college students in
Shanghai, China, in 2014. These students lived in dormitories that were randomized into 2 groups and alternated
the use of true or sham air puriﬁers for 48 h with a 2-week washout interval. We measured 14 circulating
biomarkers of inﬂammation, coagulation, and vasoconstriction; lung function; blood pressure (BP); and fractional
exhaled nitric. We applied linear mixed-effect models to evaluate the effect of the intervention on health outcome
variables.
RESULTS On average, air puriﬁcation resulted in a 57% reduction in PM2.5 concentration, from 96.2 to 41.3 mg/m3,
within hours of operation. Air puriﬁcation was signiﬁcantly associated with decreases in geometric means of several
circulating inﬂammatory and thrombogenic biomarkers, including 17.5% in monocyte chemoattractant protein-1, 68.1%
in interleukin-1b, 32.8% in myeloperoxidase, and 64.9% in soluble CD40 ligand. Furthermore, systolic BP, diastolic BP,
and fractional exhaled nitrous oxide were signiﬁcantly decreased by 2.7%, 4.8%, and 17.0% in geometric mean,
respectively. The impacts on lung function and vasoconstriction biomarkers were beneﬁcial but not statistically
signiﬁcant.
CONCLUSIONS This intervention study demonstrated clear cardiopulmonary beneﬁts of indoor air puriﬁcation among
young, healthy adults in a Chinese city with severe ambient particulate air pollution. (Intervention Study on the Health
Impact of Air Filters in Chinese Adults; NCT02239744) (J Am Coll Cardiol 2015;65:2279–87) © 2015 by the American
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ABBR EV I A T I ON S
AND ACRONYMS
BP = blood pressure
CI = conﬁdence interval
CRP = C-reactive protein
FeNO = fractional exhaled
nitric oxide
MCP-1 = monocyte
chemoattractant protein-1
PM2.5 = particulate matter with
an aerodynamic diameter
<2.5 mm
sCD40L = soluble CD40 ligand
TNF-a = tumor necrosis
factor-a
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2280N umerous studies have demon-strated that ambient ﬁne particu-late (particulate matter with an
aerodynamic diameter <2.5 mm, PM2.5) air
pollution is signiﬁcantly associated with
increased cardiopulmonary morbidity and
mortality (1,2). Furthermore, PM2.5 may exac-
erbate cardiopulmonary symptoms, some-
times even within hours of exposure, and
may result in serious adverse outcomes,
such as chronic obstructive pulmonary dis-
ease (3), myocardial infarction (4), heart fail-
ure (5), fatal arrhythmias (6), sudden cardiac
arrest (7), and stroke (8). The underlying
biological mechanisms for these associationsSEE PAGE 2288are not yet well understood, although there are hy-
potheses that implicate inﬂammation, impaired
lung function, oxidative stress, increased arterial
blood pressure (BP), endothelial dysfunction, blood
coagulation, arterial vasoconstriction, and altered
cardiac autonomic function (1).
China has one of the highest levels of ambient
PM2.5 in the world. It was estimated that ambient
PM2.5 contributed to more than 1.2 million deaths
and a loss of 24 million healthy years in China and
ranked fourth among all contributions to the health
burden (9). Outdoor PM2.5 can penetrate indoors. In
China, urban residents on average spend 87% of
their time indoors, and this percentage may be
even higher for vulnerable subgroups, such as
young children and the elderly population (10).
Therefore, it is critically important to identify ways
to effectively reduce indoor exposure to PM2.5
of outdoor origin. Unlike the outdoor environment,
a substantial reduction of PM2.5 can be achieved in
the indoor environment simply by using air ﬁlters,
cleaners, or puriﬁers. Indeed, several previous
studies suggest potential beneﬁts of indoor use of
air ﬁlters on cardiopulmonary health (11–14). How-
ever, these studies were conducted in less polluted
countries, and empirical evidence from China is
lacking.
Therefore, we conducted a randomized, double-
blind crossover study to examine whether short-
term use of air puriﬁers improves cardiopulmonary
health among healthy young adults in Shanghai, the
largest city in China. We chose circulating biomarkers
and lung function as the primary endpoints because
they have been consistently associated with air
pollution in observational studies (15–17). The sec-
ondary endpoints included BP and indicators of
respiratory inﬂammation.METHODS
STUDY PARTICIPANTS AND DESIGN. We recruited
35 healthy college students on the basis of sample
size calculations for the primary endpoints using
noninferiority tests in the software PASS version 11
(NCSS, LLC, Kaysville, Utah) (18,19). We set the sig-
niﬁcance level (alpha) at 0.05 with 80% power and
estimated the noninferior margins and standard de-
viations of primary endpoints on the basis of data from
2 quasi-experimental air pollution studies among
healthy college students in China (17,20). Our study
participants were from 10 dormitory rooms (each
approximately 20 m2) in 2 adjacent buildings, with 3 or
4 participants per room. All participants and their
roommates were nonsmokers. Their rooms were
thoroughly cleaned before the intervention to ensure
that there were no observable indoor sources of air
pollution. All subjects declared that they had no clini-
cally diagnosed chronic cardiopulmonary diseases.
The study was conducted during several weekends
of 2014 at the Fenglin campus of Fudan University,
located in the central urban area of Shanghai. This
intervention was designed as a randomized, double-
blind crossover study. To be speciﬁc, the 10 rooms
were randomized into 2 groups of 5 rooms each. One
group used an air puriﬁer placed in the center of the
room for 48 h, which corresponded to 2 weekends,
followed by a 2-week washout period, and then used
a sham air puriﬁer under the same conditions for
another 48 h. The other group simply reversed the
order in which the real and sham air puriﬁers were
used. All rooms used the same qualiﬁed air puriﬁers
(model FAP04, 3M Filtrete, Shanghai, China), with
the only difference being removal of the ﬁlter gauze
in the sham puriﬁers. The air pollution autosensing
feature of the air puriﬁers was disabled in both
groups. All participants and research staff were blin-
ded to the group assignment. We requested all par-
ticipants to stay in their dormitory room with the
windows and doors closed throughout each 48-h
intervention period. We delivered food and drinks
to each room during the intervention period. All in-
terventions started at 8 AM to avoid issues related
to diurnal variation. We evaluated health endpoints
and drew blood immediately after the completion of
each 48-h intervention.
The Institutional Review Board of the School of
Public Health, Fudan University approved the study
protocol, and all participants provided written in-
formed consent before enrollment. This study was
registered (Clinical Trials identiﬁer NCT02239744).
EXPOSURE ASSESSMENT. We measured indoor and
outdoor PM2.5 concentrations in real time using the
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2281TSI SidePak Personal Aerosol Monitor AM510 (TSI
Inc., St. Paul, Minnesota). This monitor was installed
indoors at least 1 m away from the air puriﬁer. In
addition, we also installed an outdoor monitor on
the rooftop of 1 dormitory building to represent
the outdoor PM2.5 levels of all rooms. Before the
intervention, all devices were factory calibrated to
Arizona Test Dust and externally calibrated to a
neighboring government-controlled ambient monitor
that measured PM2.5 using the method of tapered
element oscillating microbalance. At the beginning of
each intervention day, we calibrated the SidePak
using the manufacturer-supplied zero ﬁlter and ap-
plied clean grease to the impactor. We also placed a
HOBO data logger (Onset Computer Corporation,
Pocasset, Massachusetts) to monitor indoor temper-
ature and relative humidity. We recorded these
environmental data on an hourly basis and used the
48-h average as the uniform exposure level for the 3
or 4 subjects in each room.
HEALTH MEASUREMENTS. At baseline, we collected
basic demographic information such as age and sex.
We also measured height and weight to calculate the
body mass index. Immediately after each interven-
tion period, we drew a blood sample and measured
the health indicators mentioned later.
Ci rcu lat ing b iomarkers . Peripheral blood samples
(5 ml) were drawn by a nurse, separated into serum
and plasma, and stored at 80C within 30 min.
We measured the levels of 14 circulating biomarkers:
1) 8 biomarkers of inﬂammation, including C-reactive
protein (CRP), ﬁbrinogen, P-selectin, monocyte
chemoattractant protein (MCP)-1, interleukin-1b,
interleukin-6, tumor necrosis factor (TNF)-a, and
myeloperoxidase; 2) 4 biomarkers of coagulation,
including soluble CD40 ligand (sCD40L), plasminogen
activator inhibitor-1, tissue plasminogen activator,
and D-dimer; and 3) 2 biomarkers of vasoconstriction,
including endothelin-1 and angiotensin-converting
enzyme. We measured CRP, ﬁbrinogen, P-selectin,
MCP-1, TNF-a, myeloperoxidase, and D-dimer using
the Millipore MILLIPLEX MAP human cytokine/
chemokine kit (Millipore Corp., Billerica, Massachu-
setts). We measured the other biomarkers using
enzyme-linked immunosorbent assays. All biomarker
tests were performed according to the manufacturer’s
instructions.
Lung funct ion . A respiratory physician measured
forced vital capacity, forced expiratory volume in 1 s
(FEV1), and peak expiratory ﬂow of each partici-
pant using Jaeger MasterLab equipment (Würzburg,
Germany) that meets American Thoracic Society
criteria. The volume signal was calibrated at least
once per testing day with a 3.0-liter syringe connectedto the pneumotachograph, in accordance with the
manufacturer’s recommendations. We instructed
participants to perform at least 3 forced expiratory
lung function maneuvers to obtain a minimum of 2
acceptable and reproducible values, and we recorded
the best results.
Blood pressure . After sitting in a quiet room for
at least 5 min, participants had their left upper arm
BP measured by trained technicians using a mercury
sphygmomanometer at least 3 times, with 2-min
minimal intervals between measurements. The sec-
ond and third sets of readings were averaged to
obtain systolic BP and diastolic BP. Pulse pressure
was calculated as the difference between systolic
BP and diastolic BP. If the differences among the 3
measurements were more than 5 mm Hg, a new round
of measurements were arranged.
Fractional exhaled nitric oxide. Fractional exhaled nitric
oxide (FeNO) is an established biomarker of respira-
tory inﬂammation and has been widely used in
epidemiological studies because of its high sensi-
tivity, speciﬁcity, and noninvasive nature (21). We
measured FeNO levels using a portable NIOX MINO
machine (Aerocrine AB, Solna, Sweden) according
to standardized procedures recommended by the
American Thoracic Society and the European Respi-
ratory Society.
STATISTICAL ANALYSES. Because the distributions
of the health outcome variables were all skewed, we
log-transformed them before statistical analysis. To
examine potential effects caused by the order of
intervention, we compared health endpoints between
the 2 groups with different treatment order using
the 2-sample Wilcoxon rank sum (Mann-Whitney)
test (19). To account for the repeated measurement of
health endpoints under the 2 experimental scenarios,
we applied linear mixed-effect models to investigate
the effect of air puriﬁcation on outcome variables
(12). This automatically allows each subject to serve
as his or her own control over time and also adjusts
for between-subject covariates that do not change
over time. The intervention was coded as a dummy
variable (i.e., 1 for true-puriﬁed scenario and 0 for
sham-puriﬁed scenario) and was analyzed as a ﬁxed
effect in the model. We incorporated random in-
tercepts for subjects to account for intraindividual
correlations between repeated measurements, as well
as interindividual correlations of repeated measures
in each room (14). We also controlled for the following
variables as ﬁxed-effect covariates: age, sex, body
mass index, indoor temperature, and indoor relative
humidity.
Because the trial was completed in about one-half
a month, we did not control for the temporal trends
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2282of the health measurements. Furthermore, ambient
gaseous air pollutants did not confound the analyses,
because their concentrations were exactly the same
between the 2 scenarios because of the 1:1 crossover
design. Similarly, the potentially lagging confounding
effects of ambient air pollution and temperature
may also be excluded from the ﬁnal models. We
calculated the effect of air puriﬁcation as a percent
change of the geometric mean and its 95% conﬁdence
interval (CI) in a health endpoint comparing the true-
puriﬁed air scenario with the sham intervention. As
a sensitivity analysis, we replaced the dummy vari-
able of the intervention with indoor PM2.5 concen-
trations in the model discussed earlier to examine
whether an empirical decrease in indoor PM2.5 could
lead to a change in health indicators.
All statistical tests were 2-sided with alpha ¼ 0.05.
All analyses were conducted with the “lme4” package
of R software (version 2.15.3, R Development Core
Team).
RESULTS
DESCRIPTIVE STATISTICS. Study participants were
25 females and 10 males with a mean age of 23  2
years and an average body mass index of 22 kg/m2.
All participants completed this study. According to
the self-administrated questionnaire, they stayed in-
doors almost the entire time and stayed within the
central urban area of Shanghai during the wash-
out period. Furthermore, all participants remained
healthy throughout the study period.rying PM2.5 Concentration in Outdoor Air, Sham-Puriﬁed Indoor Air,
door Air
8 12 16 20 24
Time (Hours)
28 32 36 40 44 48
oor Air Sham-purified indoor airTrue-purified indoor air
tions in sham-puriﬁed air and true-puriﬁed air are the arithmetic
ments in all dormitory rooms for a group. The hourly concentrations in
asured on the rooftop of 1 dormitory building. PM2.5 ¼ particulate
erodynamic diameter.Before the intervention, the average PM2.5 con-
centration was comparable between the 2 groups.
PM2.5 concentration was reduced markedly within
the ﬁrst 4 h of using the true air puriﬁers and
remained stable over the rest of the 48-h period
(Figure 1); in contrast, PM2.5 concentration in the
sham-puriﬁcation group was barely reduced, which
suggests that closing the windows and doors did not
efﬁciently block the penetration of outdoor PM2.5.
Table 1 summarizes the indoor and outdoor air
pollutant concentrations and meteorologic parame-
ters during the study periods. The average outdoor
concentrations of PM2.5 were 103 mg/m3, which were
much higher than those in North America and West-
ern Europe. The indoor PM2.5 concentration in rooms
with a sham air puriﬁer (96.2 mg/m3) was only slightly
lower than outdoor levels. In contrast, the mean PM2.5
concentration in rooms with a true air puriﬁer was
greatly reduced to 41.3 mg/m3, 57% lower than the
concentration of the sham group.
There were appreciable decreases in the levels
of circulating biomarkers, BP, and FeNO in the
true-puriﬁed air scenario compared with the sham-
puriﬁed air scenario (Table 2); however, the differ-
ences in lung function indicators between the 2
scenarios were not signiﬁcant. The Wilcoxon rank
sum tests did not show any statistically signiﬁcant
differences in any of the health indicators between
orders (p values ranging from 0.11 to 0.93), which
suggests that there were no order effects or in-
teractions between period and order.
REGRESSION RESULTS. Overv iew. In the mixed-
effect model analysis, compared with participants in
the sham puriﬁcation group, those assigned to true
air puriﬁcation showed decreased levels of 4 blood
biomarkers, BP, and FeNO, although nonsigniﬁcant
improvement was also observed for lung function and
several other blood biomarkers (Central Illustration,
Table 3).
Card iovascu lar hea l th . All biomarkers of system-
atic inﬂammation, coagulation, and vasoconstric-
tion decreased in response to the air puriﬁcationTABLE 1 Summary of PM2.5 and Meteorological Variables
(Arithmetic Mean  SD) in Outdoor Air, Sham-Puriﬁed Indoor
Air, and Puriﬁed Indoor Air During the Intervention Periods
Outdoor Air
Sham-Puriﬁed
Indoor Air
True-Puriﬁed
Indoor Air
PM2.5, mg/m
3 102.6  11.7 96.2  25.8 41.3  17.6
Temperature, C 16.0  1.5 19.5  1.8 19.8  1.7
Relative humidity, % 68.5  17.2 68.1  12.0 66.8  9.3
PM2.5 ¼ particulate matter <2.5 mm in aerodynamic diameter.
TABLE 2 Summary of Health Endpoints (Geometric Mean  SD) in Sham-
Puriﬁed Indoor Air and Puriﬁed Indoor Air During the Intervention Periods
Endpoints Sham-Puriﬁed Indoor Air True-Puriﬁed Indoor Air
Blood inﬂammation
CRP, ng/ml 926.3  1967.1 913.1  1734.0
Fibrinogen, ng/ml 1,122.2  280.1 1,108.2  232.8
P-selectin, ng/ml 139.0  41.6 129.4  39.3
MCP-1, pg/ml 576.1  137.5 499.1  141.1
IL-1b, pg/ml 0.06  0.09 0.02  0.08
TNF-a, pg/ml 10.3  5.2 9.6  5.3
IL-6, pg/ml 0.3  0.5 0.3  0.2
MPO, ng/ml 1,579.4  772.0 1,261.4  659.4
Blood coagulation
sCD40L, ng/ml 1.4  1.6 0.5  1.1
PAI-1, ng/ml 54.9  16.7 41.5  20.0
t-PA, pg/ml 2,245.2  807.3 2,170.0  1,035.9
D-dimer, ng/ml 1,174.6  817.2 1,001.2  988.5
Blood vasoconstriction
ET-1, pg/ml 13.1  11.3 12.1  14.4
ACE, ng/ml 102.9  32.4 101.1  31.9
Lung function
FVC, l 3.0  0.7 3.1  0.8
FEV1, l 2.8  0.5 2.8  0.5
PEF, l/s 6.6  1.2 6.6  1.3
Blood pressure
Systolic pressure, mm Hg 106.0  9.6 103.3  10.2
Diastolic pressure, mm Hg 70.9  8.6 67.9  8.9
Pulse pressure, mm Hg 34.8  5.4 34.8  5.9
Respiratory inﬂammation
FeNO, ppb 14.5  25.1 13.3  20.6
ACE ¼ angiotensin-converting enzyme; CRP ¼ C-reactive protein; ET-1 ¼ endothelin-1; FeNO ¼
fractional exhaled nitric oxide; FVC ¼ forced vital capacity; FEV1 ¼ forced expiratory volume in 1 s;
IL ¼ interleukin; MCP ¼ monocyte chemoattractant protein; MPO ¼ myeloperoxidase; PAI ¼
plasminogen activator inhibitor; PEF ¼ peak expiratory ﬂow; sCD40L ¼ soluble CD40 ligand;
TNF ¼ tumor necrosis factor; t-PA ¼ tissue plasminogen activator.
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2283intervention, although not all decreases were statis-
tically signiﬁcant. The intervention had signiﬁcant
effects on 3 of 8 inﬂammation markers and 1 of 4
coagulation markers and no signiﬁcant effects on 2
vasoconstriction markers. The magnitude of the ef-
fects varied by biomarkers. For example, the inter-
vention led to a signiﬁcant geometric mean decrease
of 17.5% (95% CI: 5.5% to 30.8%) in MCP-1, 68.1%
(95% CI: 44.3% to 81.7%) in interleukin-1b, 32.8%
(95% CI: 5.3% to 67.5%) in myeloperoxidase, and
64.9% (95% CI: 30.3% to 82.3%) in sCD40L. Systolic
and diastolic BP were decreased signiﬁcantly by 2.7%
(95% CI: 0.4% to 5.1%) and 4.8% (95% CI: 1.2% to
8.5%) in geometric mean, respectively. However,
pulse pressure was not altered with the introduction
of air puriﬁers.
Resp i ra tory heal th . FeNO level was decreased
signiﬁcantly by 17.0% (95% CI: 3.6% to 32.5%) in
geometric mean in the air puriﬁcation intervention
group. There was some indication of improved
lung function associated with this intervention,
but no evidence of statistical signiﬁcance was
observed.
Sensitivity analysis. Overall, as indicated in Table 4,
the sensitivity analysis showed positive associations
of continuous exposure to indoor PM2.5 with circu-
lating biomarkers, BP, and FeNO and inverse but
nonsigniﬁcant associations with lung function.
Inconsistent with the main analyses, lower indoor
PM2.5 exposure was signiﬁcantly associated with
lower diastolic BP but not systolic BP; furthermore,
unlike the main analyses, PM2.5 was inversely asso-
ciated with tissue plasminogen activator, but its
association with MCP-1 did not reach statistical
signiﬁcance.
DISCUSSION
China has one of the worst air pollution levels in the
world, and the government and society are making
signiﬁcant efforts to reduce air pollution levels.
Research on easy and effective means of reducing air
pollution in China may therefore have substantial
public health implications. In this crossover inter-
vention study in Shanghai, China, we found that
closing doors and windows barely reduced indoor
PM2.5 concentration. In contrast, indoor use of air
puriﬁers efﬁciently reduced indoor PM2.5 within
hours of operation. Furthermore, this improvement
in air quality resulted in improved cardiopulmonary
function in 35 generally healthy college students. To
the best of our knowledge, this is the ﬁrst study to
examine the impact of short-term puriﬁcation of
indoor air on clinical and biochemistry measures ofcardiorespiratory health in areas with severe air
pollution.
Short-term indoor air puriﬁcation may have car-
diovascular beneﬁts. In the current study, we found a
modest but statistically signiﬁcant decrease in BP
after the intervention. This ﬁnding is in contrast to
those from several previous air ﬁltration studies in
countries with cleaner air (11,12,14), which suggests
that these cardiovascular beneﬁts may be more easily
achieved in regions with severe air pollution prob-
lems. Moreover, with indoor air puriﬁcation, we
also observed improvements in nearly all of the 14
examined blood biomarkers of inﬂammation, coagu-
lation, and vasoconstriction, particularly for proin-
ﬂammatory proteins such as MCP-1, interleukin-1b,
and myeloperoxidase, but not CRP. This nonsigniﬁ-
cant effect on CRP is consistent with 2 home-based
air ﬁltration studies in Copenhagen, Denmark
(12,13), but conﬂicts with another similar study in a
wood smoke–impacted community in Canada (11).
CENTRAL ILLUSTRATION Air Puriﬁers and Cardiopulmonary Beneﬁts: Percent Change in PM2.5 and
Associated Cardiopulmonary Health Indicators Comparing the True-Puriﬁed Air Scenario to the
Sham-Puriﬁed Air Scenario
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2284In the intervention period, we found a signiﬁcant
decrease in circulating sCD40L, a surface adhesion
molecule involved in both inﬂammatory and throm-
bogenic processes (22). A prior air ﬁltration study
also reported reduced expression of other adhesion
molecules (13). However, the present study did
not demonstrate a signiﬁcant beneﬁt for the remain-
ing biomarkers, whereas these associations were
reported in several observational panel studies
(1,23,24). Consistent with another air ﬁltration study
among 37 Canadian residents (14), the nonsigniﬁcant
effects on the majority of blood biomarkers may be
explained by the relatively small sample size, which
makes the effect estimates more imprecise.
Our data also suggest beneﬁcial effects of air pu-
riﬁcation on respiratory health. For example, we
found a 17.0% reduction in FeNO, an establishedbiomarker of airway inﬂammation that can be incip-
iently induced by the inhalation of PM2.5 (25). The
current study show modest, nonsigniﬁcant beneﬁcial
impacts on lung function, probably because of the
short intervention period. Two previous intervention
studies, both conducted in areas with lower ambient
air pollution, reported conﬂicting results on indoor
air puriﬁcation and lung function. In a study in
Denmark that reduced PM2.5 from 8 to 4 mg/m3, there
was no signiﬁcant association of 2 to 14 days of indoor
air puriﬁcation with lung function improvements (13).
In the second study, 7 days of indoor air puriﬁcation
was associated with signiﬁcantly improved lung
function in young adults in Manitoba, Canada (14).
Taken together, results from this interventional
study demonstrated clear, albeit modest, cardiopul-
monary beneﬁts of using an indoor air puriﬁer in
TABLE 4 Percent Change (Geometric Mean and 95% CIs) in
Health Endpoints Associated With an Interquartile Range Change
(64 mg/m3) of Continuous Indoor PM2.5 Concentration
Health Endpoints Change 95% CI
Blood inﬂammation
CRP 3.9 14.8 to 26.6
Fibrinogen 5.4 3.1 to 14.5
P-selectin 10.0 0.8 to 21.9
MCP-1 16.1 6.3 to 26.7
IL-1b 69.7 30.6 to 120.3
TNF-a 9.1 0.6 to 19.7
IL-6 15.2 13.9 to 54.1
MPO 16.8 5.4 to 44.2
Blood coagulation
sCD40L 71.3 29.8 to 126.1
PAI-1 29.4 18.0 to 104.1
t-PA 13.3 2.1 to 26.4
D-dimer 15.8 18.6 to 64.7
Blood vasoconstriction
ET-1 29.0 11.9 to 88.7
ACE 2.6 3.3 to 8.7
Lung function
FVC 1.2 7.1 to 4.3
FEV1 3.3 8.7 to 1.8
PEF 2.5 7.9 to 2.7
Blood pressure
Systolic pressure 1.8 0.3 to 3.9
Diastolic pressure 4.0 0.9 to 7.2
Pulse pressure 0.5 8.0 to 6.5
Respiratory inﬂammation
FeNO 11.3 0.6 to 23.0
Abbreviations as in Tables 2 and 3.
TABLE 3 Percent Change (Geometric Mean and 95% CI) in
Health Endpoints Comparing the True-Puriﬁed Air Scenario to the
Sham-Puriﬁed Air Scenario
Health Endpoints Change, % 95% CI
Blood inﬂammation
CRP 6.4 29.8 to 12.8
Fibrinogen 2.2 12.9 to 7.5
P-selectin 9.2 23.3 to 3.3
MCP-1 17.5 30.8 to 5.5
IL-1b 68.1 81.7 to 44.3
TNF-a 9.5 23.2 to 2.7
IL-6 15.6 58.8 to 15.9
MPO 32.8 67.5 to 5.3
Blood coagulation
sCD40L 64.9 82.3 to 30.3
PAI-1 15.9 93.0 to 30.4
t-PA 10.6 25.5 to 2.6
D-dimer 13.1 70.5 to 25.0
Blood vasoconstriction
ET-1 35.5 107.3 to 11.4
ACE 0.2 7.7 to 6.8
Lung function
FVC 1.4 5.2 to 8.4
FEV1 3.5 2.5 to 9.9
PEF 2.0 3.9 to 8.3
Blood pressure
Systolic pressure 2.7 5.1 to 0.4
Diastolic pressure 4.8 8.5 to 1.2
Pulse pressure 0.1 8.5 to 7.7
Respiratory inﬂammation
FeNO 17.0 32.5 to 3.6
CI ¼ conﬁdence interval; other abbreviations as in Table 2.
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young adults, one could reasonably expect similar or
even larger cardiopulmonary beneﬁts of air puriﬁca-
tion among vulnerable populations, such as young
children or older adults. Furthermore, the potential for
additional beneﬁts with a longer intervention can be
expected and should be investigated. The use of air
puriﬁers offers ordinary citizens a feasible and
affordable way to reduce exposure to hazardous air
pollution in a highly polluted developing country,
such as China, leading to signiﬁcant public health
beneﬁts.
This study contributes to our understanding about
potential biological mechanisms of PM2.5 and health by
examining a short-term intervention of reducing PM2.5
exposure and a range of clinical and biochemical
markers. Previous human studies have linked short-
term PM2.5 exposure to a wide range of adverse car-
diopulmonary endpoints (1,26,27); however, most of
these were observational panel studies that evaluated
changes in health indicators in association withnatural day-to-day variations in ambient PM2.5 con-
centrations. Residual confounding may occur because
of a number of individual characteristics and envi-
ronmental factors, such as weather conditions.
Therefore, controlled-exposure interventional studies
offer a viable alternative to investigate the causal
relationship between ambient PM2.5 and health pa-
rameters (28), but this kind of evidence is largely
lacking. Overall, our results supported the biological
mechanisms proposed by previous observational
studies (1).
Our study has strengths. First, this randomized,
double-blind crossover design facilitated causal in-
ferences of air puriﬁcation, reduction of air pollut-
ants, and improved health indicators. Second, we
measured more indicators of cardiorespiratory health
than previous studies, which enabled a more sys-
tematic assessment of the potential health beneﬁts
of reducing indoor air pollution. Third, the experi-
mental environment was well controlled in that only
PM2.5 was probably different between the 2 groups,
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: In a
population chronically exposed to air pollution, even
relatively brief (2-day) puriﬁcation of indoor air can
improve cardiopulmonary health.
TRANSLATIONAL OUTLOOK: Further studies are
needed to conﬁrm these ﬁndings and develop more
efﬁcient methods for indoor air puriﬁcation to improve
public health implications.
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Finally, because this intervention study was com-
pleted over a 2-week period, we avoided potential
temporal confounding caused by seasonal changes
and changes in participant behavior.
STUDY LIMITATIONS. First, the study included only
35 participants in 10 rooms. We might therefore have
missed some potentially important but modest dif-
ferences attributable to the relatively small sample
size. Second, because of the relatively small sample
size and examination of multiple health endpoints,
our studywas considered exploratory in nature. Third,
we chose to enroll college students from school dor-
mitories with a short intervention period to better
control for potential confounding that might have
been difﬁcult to control in other study settings (e.g.,
indoor cooking, smoking, medication use, and indi-
vidual health status). However, this study strategy
might have limited the generalizability of our study
results and might have led us to underestimate or miss
some potential health effects (such as lung function)
thatmay be observedwith long-term air puriﬁcation or
in more vulnerable populations. Fourth, we did not
monitor indoor gaseous air pollutants and were
therefore unable to make a direct inference between
PM2.5 reduction and the observed health beneﬁts.
Because the dormitory rooms were almost identical,
except for the intervention, and because air puriﬁers
could not eliminate gaseous pollutants, we believe
that this is not a major concern.CONCLUSIONS
This intervention study demonstrated clear cardio-
pulmonary beneﬁts of indoor air puriﬁcation among
young, healthy adults in a Chinese city with severe
ambient particulate air pollution. Future studies
should further evaluate the potential health beneﬁts
of long-term air puriﬁcation among more vulnerable
populations, such as children, older adults, or people
with cardiopulmonary diseases.
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